Cargando…

Editorial: Local ablative therapies for the management of lung cancer

Detalles Bibliográficos
Autores principales:	Wei, Zhigang, Iezzi, Roberto, Ye, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9980420/ https://www.ncbi.nlm.nih.gov/pubmed/36874137 http://dx.doi.org/10.3389/fonc.2023.1160932

Ejemplares similares

Editorial: Controversies in the Local Management of Lung Cancer
por: Varlotto, John M., et al.
Publicado: (2018)

Microwave ablation plus camrelizumab monotherapy or combination therapy in non-small cell lung cancer
por: Huang, Yahan, et al.
Publicado: (2022)

Cost and effectiveness of microwave ablation versus video-assisted thoracoscopic surgical resection for ground-glass nodule lung adenocarcinoma
por: Han, Xiaoying, et al.
Publicado: (2022)

A prognostic model for predicting progression-free survival in patients with advanced non-small cell lung cancer after image-guided microwave ablation plus chemotherapy
por: Kong, Fanhao, et al.
Publicado: (2023)

Editorial: Modern neurosurgical management of gliomas, including local therapies
por: Spallone, Aldo
Publicado: (2023)

Synchronous Microwave Ablation Combined With Cisplatin Intratumoral Chemotherapy for Large Non-Small Cell Lung Cancer
por: Huang, Guanghui, et al.
Publicado: (2022)

Percutaneous Radiofrequency Ablation Is an Effective Method for Local Control of Liver Metastases From Lung Cancer
por: Zhang, Zhong-Yi, et al.
Publicado: (2022)

Crosstalk between microwave ablation and ferroptosis: The next hot topic?
por: Yu, Lu, et al.
Publicado: (2023)

Microwave ablation induces abscopal effect via enhanced systemic antitumor immunity in colorectal cancer
por: Yu, Lu, et al.
Publicado: (2023)

Editorial: The effect of anti-cancer drug therapies in the treatment of lung cancer
por: Pisapia, Pasquale, et al.
Publicado: (2022)

Editorial: Radiofrequency ablation in liver cancers: Investigations of efficacy as monotherapy and polytherapy
por: Rompianesi, Gianluca
Publicado: (2022)

Assessment of Ablation Therapy in Pancreatic Cancer: The Radiologist’s Challenge
por: Granata, Vincenza, et al.
Publicado: (2020)

Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer
por: Puri, Sonam, et al.
Publicado: (2020)

Editorial: Quality of Life and Side Effects Management in Lung Cancer Treatment
por: Molassiotis, Alex, et al.
Publicado: (2021)

Risk Adapted Ablative Radiotherapy After Intensive Chemotherapy for Locally Advanced Pancreatic Cancer
por: Rossi, Gabriella, et al.
Publicado: (2021)

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options
por: Zaorsky, Nicholas G., et al.
Publicado: (2020)

Dose-Intensified Stereotactic Ablative Radiation for Localized Prostate Cancer
por: Chen, Lily, et al.
Publicado: (2022)

Editorial: Application of nanotechnology in diagnosis and/or therapy of non-small cell lung cancer
por: Shen, Qinglin, et al.
Publicado: (2023)

Long-term outcome following microwave ablation of lung metastases from colorectal cancer
por: Han, Yue, et al.
Publicado: (2022)

Stereotactic ablative radiotherapy for acquired resistance to EGFR therapy in metastatic non-small cell lung cancer
por: Chicas-Sett, Rodolfo, et al.
Publicado: (2023)

Microwave ablation therapy assisted by artificial pneumothorax and artificial hydrothorax for lung cancer adjacent to the vital organs
por: Chen, Jian, et al.
Publicado: (2022)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
por: Blacksburg, Seth R., et al.
Publicado: (2020)

Editorial: Impact of immunotherapy in lung cancer
por: Ferreira, Marion, et al.
Publicado: (2022)

Microwave ablation with local pleural anesthesia for subpleural pulmonary nodules: our experience
por: Meng, Liangliang, et al.
Publicado: (2022)

Editorial: Molecular influences in therapies in ovarian cancer
por: Restaino, Stefano, et al.
Publicado: (2022)

Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety
por: Hu, Hong-Tao, et al.
Publicado: (2022)

Image-guided percutaneous ablation for lung malignancies
por: Shang, Youlan, et al.
Publicado: (2022)

Editorial: Perioperative management and cancer outcome
por: Tao, Yiying, et al.
Publicado: (2023)

Editorial: Impact of tumor microenvironment on lung cancer
por: Levantini, Elena
Publicado: (2023)

Editorial: Brain and leptomeningeal metastases in lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2023)

Editorial: Stereotactic body radiotherapy for lung cancer
por: Liu, An, et al.
Publicado: (2023)

Editorial: Primary and acquired resistance in lung cancer
por: Bruno, Rossella, et al.
Publicado: (2023)

Editorial: Recent advances of drug resistance research in colorectal cancer therapy
por: Ye, Chenyang, et al.
Publicado: (2022)

Management of Biochemical Recurrence after Primary Localized Therapy for Prostate Cancer
por: Darwish, Oussama M., et al.
Publicado: (2012)

Editorial: Nanomedicine in Cancer Targeting and Therapy
por: Longo, João Paulo Figueiró, et al.
Publicado: (2021)

Current Management of Oligometastatic Lung Cancer and Future Perspectives: Results of Thermal Ablation as a Local Ablative Therapy
por: Ghosn, Mario, et al.
Publicado: (2021)

Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
por: Wang, Bin, et al.
Publicado: (2022)

Local therapy treatment conditions for oligometastatic non-small cell lung cancer
por: Zhang, Suli, et al.
Publicado: (2022)

Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
por: Yang, Wei-Yu, et al.
Publicado: (2022)

Longitudinal Monitoring of EGFR and PIK3CA Mutations by Saliva-Based EFIRM in Advanced NSCLC Patients With Local Ablative Therapy and Osimertinib Treatment: Two Case Reports
por: Li, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gs7nnc3b55i07d3iata9cf4b96